D
Theravance Biopharma, Inc. TBPH
$13.91 $0.251.83% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments 338.80M 130.86M 88.35M 91.36M 96.08M
Total Receivables 21.92M 15.35M 68.44M 16.85M 14.30M
Inventory -- -- -- -- --
Prepaid Expenses 5.57M 4.06M 4.28M 8.27M 8.93M
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 366.29M 150.26M 161.07M 116.48M 119.31M

Total Current Assets 366.29M 150.26M 161.07M 116.48M 119.31M
Net Property, Plant & Equipment 33.13M 34.46M 35.77M 37.12M 39.96M
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 26.61M 158.86M 157.32M 202.50M 202.77M
Total Assets 426.04M 343.58M 354.16M 356.11M 362.03M

Total Accounts Payable 1.68M 2.41M 2.24M 1.45M 1.67M
Total Accrued Expenses 15.37M 12.43M 13.28M 11.30M 10.56M
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 10.90M 10.81M 10.71M 4.20M 4.22M
Total Finance Division Other Current Liabilities 26.70M 5.85M 5.85M 6.49M 6.49M
Total Other Current Liabilities 26.70M 5.85M 5.85M 6.49M 6.49M
Total Current Liabilities 54.63M 31.50M 32.09M 23.44M 22.95M

Total Current Liabilities 54.63M 31.50M 32.09M 23.44M 22.95M
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases 35.56M 37.35M 39.11M 40.79M 42.44M
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 110.99M 108.75M 107.42M 106.23M 102.95M
Total Liabilities 201.19M 177.60M 178.62M 170.45M 168.34M

Common Stock & APIC 1.15B 1.15B 1.14B 1.14B 1.13B
Retained Earnings -924.27M -979.10M -965.52M -950.00M -937.30M
Treasury Stock & Other -10.00K -- 7.00K 50.00K -22.00K
Total Common Equity 224.85M 165.98M 175.55M 185.65M 193.69M

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 224.85M 165.98M 175.55M 185.65M 193.69M
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 224.85M 165.98M 175.55M 185.65M 193.69M